Further, in vitro studies indicate that cultured breast cancer cells exhibit high YAP/TAZ activity and confer drug-resistance to many routinely used chemotherapeutic drugs, such as taxol, 5-fluorouracil, and doxorubicin (182–184). This evidence concerns the gene YAP1 and breast carcinoma.